Logo 2839 Logo 2839 (Fenofibric Acid Delayed-Release 135 mg)

Pill with imprint Logo 2839 Logo 2839 is Brown & Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Actavis Pharma, Inc..

Fenofibric acid is used in the treatment of hypertriglyceridemia; high cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo 2839 Logo 2839

Fenofibric Acid Delayed-Release

Imprint

Logo 2839 Logo 2839

Strength

135 mg

Color

Brown & Yellow

Size

22.00 mm

Shape

Capsule-shape

Availability

Prescription only

Drug Class

Fibric acid derivatives

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Actavis Pharma, Inc.

National Drug Code (NDC)

00228-2839

Inactive Ingredients

ammonio methacrylate copolymer type A, ammonio methacrylate copolymer type B, hydroxypropyl cellulose (type l), sodium lauryl sulfate, sucrose, corn starch, magnesium silicate, triethyl citrate, gelatin, titanium dioxide, ferric oxide yellow, ferrosoferric oxide, potassium hydroxide, propylene glycol, shellac, ammonia, ferric oxide red

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer